22 results on '"Passeri, Daniela"'
Search Results
2. Synthesis, physicochemical properties, and biological activity of bile acids 3-glucuronides: Novel insights into bile acid signalling and detoxification.
- Author
-
Mostarda, Serena, Passeri, Daniela, Carotti, Andrea, Cerra, Bruno, Colliva, Carolina, Benicchi, Tiziana, Macchiarulo, Antonio, Pellicciari, Roberto, and Gioiello, Antimo
- Subjects
- *
GLUCURONIDE synthesis , *BILE acids , *METABOLIC detoxification , *FARNESOID X receptor , *GLUCURONIDATION , *BIOACTIVE compounds , *NUCLEAR receptors (Biochemistry) , *HOMEOSTASIS - Abstract
Glucuronidation is considered an important detoxification pathway of bile acids especially in cholestatic conditions. Glucuronides are less toxic than the parent free forms and are more easily excreted in urine. However, the pathophysiological significance of bile acid glucuronidation is still controversial and debated among the scientific community. Progress in this field has been strongly limited by the lack of appropriate methods for the preparation of pure glucuronides in the amount needed for biological and pharmacological studies. In this work, we have developed a new synthesis of bile acid C3-glucuronides enabling the convenient preparation of gram-scale quantities. The synthesized compounds have been characterized in terms of physicochemical properties and abilities to modulate key nuclear receptors including the farnesoid X receptor (FXR). In particular, we found that C3-glucuronides of chenodeoxycholic acid and lithocholic acid, respectively the most abundant and potentially cytotoxic species formed in patients affected by cholestasis, behave as FXR agonists and positively regulate the gene expression of transporter proteins, the function of which is critical in human conditions related to imbalances of bile acid homeostasis. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
3. Discovery of 3α,7α,11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders.
- Author
-
Pellicciari, Roberto, Passeri, Daniela, De Franco, Francesca, Mostarda, Serena, Filipponi, Paolo, Colliva, Carolina, Gadaleta, Raffaella Maria, Franco, Placido, Carotti, Andrea, Macchiarulo, Antonio, Roda, Aldo, Moschetta, Antonio, and Gioiello, Antimo
- Subjects
- *
DEOXYCHOLIC acid , *FARNESOID X receptor , *BILE acids , *HYDROXYL group , *HYDROXYLATION , *STRUCTURE-activity relationship in pharmacology - Abstract
As a continuation of previous efforts in mapping functional hot spots on the bile acid scaffold, we here demonstrate that the introduction of a hydroxy group at the C11β position affords high selectivity for FXR. In particular, the synthesis and FXR/TGR5 activity of novel bile acids bearing different hydroxylation patterns at the C ring are reported and discussed from a structure-activity standpoint. The results obtained led us to discover the first bile acid derivative endowed with high potency and selectivity at the FXR receptor, 3α,7α,11β-trihydroxy-6α-ethyl-5β-cholan-24-oic acid (TC-100, 7) which also shows a remarkable physicochemical and pharmacological profile. Compound 7 combines the excellent physicochemical properties of hydrophilic bile acids such as ursodeoxycholic acid, with the distinct ability to specifically bind and regulate FXR activity in vivo, thus providing a bona fide novel therapeutic agent to treat enterohepatic disorders such as cholestasis, NASH, and inflammatory bowel disease. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
4. ChemInform Abstract: Concepts and Molecular Aspects in the Polypharmacology of PARP-1 Inhibitors.
- Author
-
Passeri, Daniela, Camaioni, Emidio, Liscio, Paride, Sabbatini, Paola, Ferri, Martina, Carotti, Andrea, Giacche, Nicola, Pellicciari, Roberto, Gioiello, Antimo, and Macchiarulo, Antonio
- Subjects
- *
PHARMACOLOGY , *ENZYME inhibitors , *MOLECULAR pharmacology - Abstract
Review: [52 refs. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
5. Novel 1,4-Dihydropyridine Derivatives as Mineralocorticoid Receptor Antagonists.
- Author
-
Pérez-Gordillo, Felipe Luis, Serrano-Morillas, Natalia, Acosta-García, Luz Marina, Aranda, María Teresa, Passeri, Daniela, Pellicciari, Roberto, Pérez de Vega, María Jesús, González-Muñiz, Rosario, Alvarez de la Rosa, Diego, and Martín-Martínez, Mercedes
- Subjects
- *
MINERALOCORTICOID receptors , *STEROID receptors , *TRANSCRIPTION factors , *DRUG design , *BLOOD pressure , *PLANT translocation - Abstract
The mineralocorticoid receptor (MR) belongs to the steroid receptor subfamily of nuclear receptors. MR is a transcription factor key in regulating blood pressure and mineral homeostasis. In addition, it plays an important role in a broad range of biological and pathological conditions, greatly expanding its interest as a pharmacological target. Non-steroidal MR antagonists (MRAs) are of particular interest to avoid side effects and achieve tissue-specific modulation of the receptor. The 1,4-dihydropyridine (1,4-DHP) ring has been identified as an appropriate scaffold to develop non-steroidal MRAs. We report the identification of a novel series of 1,4-DHP that has been guided by structure-based drug design, focusing on the less explored DHP position 2. Interestingly, substituents at this position might interfere with MR helix H12 disposition, which is essential for the recruitment of co-regulators. Several of the newly synthesized 1,4-DHPs show interesting properties as MRAs and have a good selectivity profile. These 1,4-DHPs promote MR nuclear translocation with less efficiency than the natural agonist aldosterone, which explains, at least in part, its antagonist character. Molecular dynamic studies are suggestive of several derivatives interfering with the disposition of H12 in the agonist-associated conformation, and thus, they might stabilize an MR conformation unable to recruit co-activators. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy.
- Author
-
Marchand, Jean-Rémy, Carotti, Andrea, Passeri, Daniela, Filipponi, Paolo, Liscio, Paride, Camaioni, Emidio, Pellicciari, Roberto, Gioiello, Antimo, and Macchiarulo, Antonio
- Subjects
- *
ALLOSTERIC proteins , *CELLULAR signal transduction , *POLYMERASES , *ISCHEMIA treatment , *ENZYME inhibitors , *MOLECULAR dynamics , *FLUORESCENCE anisotropy - Abstract
The inhibition of the poly(ADP-ribose) polymerase (PARP) family members is a strategy pursued for the development of novel therapeutic agents in a range of diseases, including stroke, cardiac ischemia, cancer, inflammation and diabetes. Even though some PARP-1 inhibitors have advanced to clinical setting for cancer therapy, a great deal of attention is being devoted to understand the polypharmacology of current PARP inhibitors. Besides blocking the catalytic activity, recent works have shown that some PARP inhibitors exhibit a poisoning activity, by trapping the enzyme at damaged sites of DNA and forming cytotoxic complexes. In this study we have used microsecond molecular dynamics to study the allosteric reverse signalling that is at the basis of such an effect. We show that Olaparib, but not Veliparib and HYDAMTIQ, is able to induce a specific conformational drift of the WGR domain of PARP-1, which stabilizes PARP-1/DNA complex through the locking of several salt bridge interactions. Fluorescence anisotropy assays support such a mechanism, providing the first experimental evidence that HYDAMTIQ, a potent PARP inhibitor with neuroprotective properties, is less potent than Olaparib to trap PARP-1/DNA complex. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
7. Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi.
- Author
-
Matera, Maria G., Calzetta, Luigino, Passeri, Daniela, Facciolo, Francesco, Rendina, Erino A., Page, Clive, Cazzola, Mario, and Orlandi, Augusto
- Subjects
- *
EPITHELIUM , *HISTAMINE , *IMMUNOHISTOCHEMISTRY , *REVERSE transcriptase polymerase chain reaction , *ACETYLCHOLINE , *EPITHELIAL cells , *BRONCHI - Abstract
BACKGROUND AND PURPOSE Brain natriuretic peptide (BNP) plays an important role in several biological functions, including bronchial relaxation. Here, we have investigated the role of BNP and its cognate receptors in human bronchial tone. EXPERIMENTAL APPROACH Effects of BNP on responses to carbachol and histamine were evaluated in non-sensitized, passively sensitized, epithelium-intact or denuded isolated bronchi and in the presence of methoctramine, N(ω) -nitro-L-arginine methyl ester (L-NAME) and aminoguanidine. Natriuretic peptide receptors (NPRs) were investigated by immunohistochemistry, RT-PCR and real-time PCR. Release of NO and acetylcholine from bronchial tissues and cultured BEAS-2B bronchial epithelial cells was also investigated. KEY RESULTS BNP reduced contractions mediated by carbachol and histamine, with decreased E(max) (carbachol: 22.7 ± 4.7%; histamine: 59.3 ± 1.8%) and increased EC(50) (carbachol: control 3.33 ± 0.88 µM, BNP 100 ± 52.9 µM; histamine: control 16.7 ± 1.7 µM, BNP 90 ± 30.6 µM); BNP was ineffective in epithelium-denuded bronchi. Among NPRs, only atrial NPR (NPR1) transcripts were detected in bronchial tissue. Bronchial NPR1 immunoreactivity was detected in epithelium and inflammatory cells but faint or absent in airway smooth muscle cells. NPR1 transcripts in bronchi increased after incubation with BNP, but not after sensitization. Methoctramine and quinine abolished BNP-induced relaxant activity. The latter was associated with increased bronchial mRNA for NO synthase and NO release, inhibited by L-NAME and aminoguanidine. In vitro, BNP increased acetylcholine release from bronchial epithelial cells, whereas NO release was unchanged. CONCLUSIONS AND IMPLICATIONS Epithelial cells mediate the BNP-induced relaxant activity in human isolated bronchi. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
8. Chemical exploration of TGR5 functional hot-spots: Synthesis and structure-activity relationships of C7- and C23-Substituted cholic acid derivatives.
- Author
-
Rosatelli, Emiliano, Carotti, Andrea, Cerra, Bruno, De Franco, Francesca, Passeri, Daniela, Pellicciari, Roberto, and Gioiello, Antimo
- Subjects
- *
CHOLIC acid , *STRUCTURE-activity relationships , *ACID derivatives , *HOMEOSTASIS , *BILE acids , *DRUG discovery , *METABOLIC regulation - Abstract
The activation of TGR5 bestows on bile acids the ability to modulate nongenomic signaling pathways, which are responsible of physiological actions including immunosuppressive and anti-inflammatory properties as well as the regulation of glucose metabolism and energy homeostasis. TGR5 agonists have therefore emerged in drug discovery and preclinical appraisals as promising compounds for the treatment of liver diseases and metabolic syndrome. In this study, we have been devising site-selected chemical modifications of the bile acid scaffold to provide novel chemical tools able to modulate the functions of TGR5 in different tissues. Biological results of the tested collection of semisynthetic cholic acid derivatives were used to extend the structure-activity relationships of TGR5 agonists and to clarify the molecular basis and functional role of TGR5 hot-spots in the receptor activation and selectivity. Some unexpected properties deriving from the molecular structure of bile acids have been unveiled as relevant to the receptor activation and may hence be used to design novel, selective and potent TGR5 agonists. [Display omitted] • The synthesis of a collection of novel semisynthetic cholic acid derivatives is reported. • The C 7 β-butyl-CA (8) and the C 23 -difluoro-CA (19) were identified as selective low micromolar TGR5 agonists. • Biological data and computational modelling evidenced for the first time the negative impact of the 6α-ethyl group in the TGR5 activity of bile acids. • Unprecedented insights into the functional role of TGR5 hot-spots are reported and may be explored to design potent and selective TGR5 agonists. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells.
- Author
-
Di Bello, Elisabetta, Sian, Veronica, Bontempi, Giulio, Zwergel, Clemens, Fioravanti, Rossella, Noce, Beatrice, Castiello, Carola, Tomassi, Stefano, Corinti, Davide, Passeri, Daniela, Pellicciari, Roberto, Mercurio, Ciro, Varasi, Mario, Altucci, Lucia, Tripodi, Marco, Strippoli, Raffaele, Nebbioso, Angela, Valente, Sergio, and Mai, Antonello
- Subjects
- *
HISTONE deacetylase inhibitors , *CANCER cells , *MICRORNA , *CANCER cell proliferation , *CELL cycle , *APOPTOSIS - Abstract
After over 30 years of research, the development of HDAC inhibitors led to five FDA/Chinese FDA-approved drugs and many others under clinical or preclinical investigation to treat cancer and non-cancer diseases. Herein, based on our recent development of pyridine-based isomers as HDAC inhibitors, we report a series of novel 5-acylamino-2-pyridylacrylic- and -picolinic hydroxamates and 2′-aminoanilides 5 – 8 as anticancer agents. The hydroxamate 5d proved to be quite HDAC3/6-selective exhibiting IC 50 values of 80 and 11 nM, respectively, whereas the congener 5e behaved as inhibitor of HDAC1-3, −6, −8, and −10 (class I/IIb-selective inhibitor) at nanomolar level. Compound 5e provided a huge antiproliferative activity (nanomolar IC 50 values) against both haematological and solid cancer cell lines. In leukaemia U937 cells, the hydroxamate 5d and the 2′-aminoanilide 8f induced remarkable cell death after 48 h, with 76% and 100% pre-G1 phase arrest, respectively, showing a stronger effect with respect to SAHA and MS-275 used as reference compounds. In U937 cells, the highest dose- and time-dependent cytodifferentiation was obtained by the 2′-aminoanilide 8d (up to 35% of CD11c positive/propidium iodide negative cells at 5 μM for 48 h). The same 8d and the hydroxamates 5d and 5e were the most effective in inducing p21 protein expression in the same cell line. Mechanistically, 5d, 5e, 8d and 8f increased mRNA expression of p21, BAX and BAK, downregulated cyclin D1 and BCL-2 and modulated pro- and anti-apoptotic microRNAs towards apoptosis induction. Finally, 5e strongly arrested proliferation in nine different haematological cancer cell lines, with dual-digit nanomolar potency towards MV4-11, Kasumi-1, and NB4, being more potent than mocetinostat, used as reference drug. [Display omitted] • Novel Pyridine-Based Hydroxamates and 2′-Aminoanilides have been developed. • Compound 5d displayed HDAC3 and -6 selective nanomolar inhibition in vitro. • Compound 5d+5e strongly impaired cancer cells proliferation. • Compound 8d induced high U937 cell cytodifferentiation. • Compounds 5d, 5e, 8d+8f induced cell cycle arrest modulating cell cycle-/apoptosis-related miRNAs expression in U937 cells. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. Development of 1,2,4-Oxadiazoles as Potent and Selective Inhibitors of the Human Deacetylase Sirtuin 2: Structure-Activity Relationship, X-ray Crystal Structure, and Anticancer Activity.
- Author
-
Moniot, Sébastien, Forgione, Mariantonietta, Lucidi, Alessia, Hailu, Gebremedhin S., Nebbioso, Angela, Carafa, Vincenzo, Baratta, Francesca, Altucci, Lucia, Giacché, Nicola, Passeri, Daniela, Pellicciari, Roberto, Antonello Mai, Steegborn, Clemens, and Rotili, Dante
- Subjects
- *
OXADIAZOLES , *CANCER treatment , *SIRTUINS , *CRYSTAL structure , *CRYSTALLINITY - Abstract
Sirt2 is a target for the treatment of neurological, metabolic, and age-related diseases including cancer. Here we report a series of Sirt2 inhibitors based on the 1,2,4-oxadiazole scaffold. These compounds are potent Sirt2 inhibitors active at single-digit μM level by using the Sirt2 substrate α-tubulin-acetylLys40 peptide and inactive up to 100 μM against Sirt1, -3, and -5 (deacetylase and desuccinylase activities). Their mechanism of inhibition is uncompetitive toward both the peptide substrate and NAD+, and the crystal structure of a 1,2,4-oxadiazole analog in complex with Sirt2 and ADP-ribose reveals its orientation in a still unexplored subcavity useful for further inhibitor development. Tested in leukemia cell lines, 35 and 39 induced apoptosis and/or showed antiproliferative effects at 10 or 25 μM after 48 h. Western blot analyses confirmed the involvement of Sirt2 inhibition for their effects in NB4 and in U937 cells. Our results provide novel Sirt2 inhibitors with a compact scaffold and structural insights for further inhibitor improvement. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
11. Development of 3α,7α-dihydroxy-6α-ethyl-24-nor-5β-cholan-23-sulfate sodium salt (INT-767): Process optimization, synthesis and characterization of metabolites.
- Author
-
Cerra, Bruno, Venturoni, Francesco, Souma, Maria, Ceccarelli, Giada, Lozza, Anna Maria, Passeri, Daniela, De Franco, Francesca, Baxendale, Ian R., Pellicciari, Roberto, Macchiarulo, Antonio, and Gioiello, Antimo
- Subjects
- *
PROCESS optimization , *SODIUM salts , *METABOLITES , *BILE acids , *ACID derivatives , *STRUCTURE-activity relationships , *SULFATION - Abstract
Herein we report our synthetic efforts in supporting the development of the bile alcohol sulfate INT-767, a FXR/TGR5 dual agonist with remarkable therapeutic potential for liver disorders. We describe the process development to a final route for large scale preparation and analogues synthesis. Key sequences include Grignard addition, a one-pot two-step shortening-reduction of the carboxylic side chain, and the final sulfation reaction. The necessity for additional steps such as the protection/deprotection of hydroxyl groups at the steroidal body was also evaluated for step-economy and formation of side-products. Critical bottlenecks such as the side chain degradation have been tackled using flow technology before scaling-up individual steps. The final synthetic route may be successfully employed to produce the amount of INT-767 required to support late-stage clinical development of the compound. Furthermore, potential metabolites have been synthesized, characterized and evaluated for their ability to modulate FXR and TGR5 receptors providing key reference standards for future drug investigations, as well as offering further insights into the structure-activity relationships of this class of compounds. [Display omitted] • The process optimization and scale-up synthesis of INT-767 is provided. • The synthesized INT-767 metabolites are weaker FXR/TGR5 agonists. • Computational analysis provides novel insights into the structure-activity relationships of bile acid derivatives. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
12. Epithelial-smooth muscle cooperation is needed for brain natriuretic peptide-dependent bronchorelaxant activity
- Author
-
Matera, Maria G., Calzetta, Luigino, Passeri, Daniela, Rogliani, Paola, and Orlandi, Augusto
- Published
- 2013
- Full Text
- View/download PDF
13. Drug-releasing mesenchymal cells strongly suppress B16 lung metastasis in a syngeneic murine model.
- Author
-
Pessina, Augusto, Leonetti, Carlo, Artuso, Simona, Benetti, Anna, Dessy, Enrico, Pascucci, Luisa, Passeri, Daniela, Orlandi, Augusto, Berenzi, Angiola, Bonomi, Arianna, Coccè, Valentina, Ceserani, Valentina, Ferri, Anna, Dossena, Marta, Mazzuca, Pietro, Ciusani, Emilio, Ceccarelli, Piero, Caruso, Arnaldo, Portolani, Nazario, and Sisto, Francesca
- Subjects
- *
MESENCHYMAL stem cells , *METASTASIS , *LUNG cancer , *ANTINEOPLASTIC agents , *CANCER cell growth , *LABORATORY mice - Abstract
Background: Mesenchymal stromal cells (MSCs) are considered an important therapeutic tool in cancer therapy. They possess intrinsic therapeutic potential and can also be in vitro manipulated and engineered to produce therapeutic molecules that can be delivered to the site of diseases, through their capacity to home pathological tissues. We have recently demonstrated that MSCs, upon in vitro priming with anti-cancer drug, become drug-releasing mesenchymal cells (Dr-MCs) able to strongly inhibit cancer cells growth. Methods: Murine mesenchymal stromal cells were loaded with Paclitaxel (Dr-MCsPTX) according to a standardized procedure and their ability to inhibit the growth of a murine B16 melanoma was verified by in vitro assays. The anti-metastatic activity of Dr-MCsPTX was then studied in mice injected i.v. with B16 melanoma cells that produced lung metastatic nodules. Lung nodules were counted under a dissecting stereomicroscope and metastasis investigated by histological analysis. Results: We found that three i.v. injections of Dr-MCsPTX on day 5, 10 and 15 after tumor injection almost completely abolished B16 lung metastasis. Dr-MCsPTX arrested into lung by interacting with endothelium and migrate toward cancer nodule through a complex mechanism involving primarily mouse lung stromal cells (mL-StCs) and SDF-1/ CXCR4/CXCR7 axis. Conclusions: Our results show for the first time that Dr-MCsPTX are very effective to inhibit lung metastasis formation. Actually, a cure for lung metastasis in humans is mostly unlikely and we do not know whether a therapy combining engineered MSCs and Dr-MCs may work synergistically. However, we think that our approach using Dr-MCs loaded with PTX may represent a new valid and additive therapeutic tool to fight lung metastases and, perhaps, primary lung cancers in human. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
14. Brain natriuretic peptide modulates calcium homeostasis and epidermal growth factor receptor gene signalling in asthmatic airways smooth muscle cells.
- Author
-
Orlandi, Augusto, Calzetta, Luigino, Doldo, Elena, Tarquini, Chiara, Matera, Maria Gabriella, and Passeri, Daniela
- Subjects
- *
PEPTIDES , *SUBCONSCIOUSNESS , *CENTRAL nervous system , *BRAIN diseases , *BRAIN injuries - Abstract
The airway epithelium acts as a barrier and provides a critical interface between the body and the external environment. Brain natriuretic peptide (BNP) plays an important role in several bronchial functions, including relaxation. BNP relaxes airways by binding and activating natriuretic peptide receptor-A expressed from the airway epithelium. Although relaxation effect has been extensively investigated, less is known about BNP-regulated intracellular biomolecular pathways leading to bronchial relaxation. To this aim, we investigated BNP effects on gene signalling of airway smooth muscle cells (ASM) obtained from donors with asthma by using a RT 2 profiler™ PCR array. When compared with control, treatment for 2 h with supernatant from BNP-treated (1 μM) bronchial epithelial cells (BEAS-2B) induced in asthmatic ASM cells a rapid reduction of transcription of EGFR and genes involving in actin and calcium homeostasis, as those of Protein kinase C (PKC) and RhoA-ROCK gene pathways. Immunofluorescence and western blotting did not shown any difference comparing control and ASM cells treated with conditioned medium from BNP-treated BEAS-2B. This study provides evidence that the effect of BNP on relaxing bronchial in ASM cells is mediated from epithelium and associates to rapid changes of EGFR and calcium homeostasis-associated gene levels. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
15. Vitamin A, Cancer Treatment and Prevention: The New Role of Cellular Retinol Binding Proteins.
- Author
-
Doldo, Elena, Costanza, Gaetana, Agostinelli, Sara, Tarquini, Chiara, Ferlosio, Amedeo, Arcuri, Gaetano, Passeri, Daniela, Scioli, Maria Giovanna, and Orlandi, Augusto
- Subjects
- *
PROTEIN metabolism , *CELL differentiation , *VITAMIN A metabolism , *APOPTOSIS , *TUMORS , *VITAMIN A , *PHYSIOLOGY ,TUMOR prevention - Abstract
Retinol and vitamin A derivatives influence cell differentiation, proliferation, and apoptosis and play an important physiologic role in a wide range of biological processes. Retinol is obtained from foods of animal origin. Retinol derivatives are fundamental for vision, while retinoic acid is essential for skin and bone growth. Intracellular retinoid bioavailability is regulated by the presence of specific cytoplasmic retinol and retinoic acid binding proteins (CRBPs and CRABPs). CRBP-1, the most diffuse CRBP isoform, is a small 15 KDa cytosolic protein widely expressed and evolutionarily conserved in many tissues. CRBP-1 acts as chaperone and regulates the uptake, subsequent esterification, and bioavailability of retinol. CRBP-1 plays a major role in wound healing and arterial tissue remodelling processes. In the last years, the role of CRBP-1-related retinoid signalling during cancer progression became object of several studies. CRBP-1 downregulation associates with a more malignant phenotype in breast, ovarian, and nasopharyngeal cancers. Reexpression of CRBP-1 increased retinol sensitivity and reduced viability of ovarian cancer cells in vitro. Further studies are needed to explore new therapeutic strategies aimed at restoring CRBP-1-mediated intracellular retinol trafficking and the meaning of CRBP-1 expression in cancer patients’ screening for a more personalized and efficacy retinoid therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
16. Synthesis of atypical bile acids for use as investigative tools for the genetic defect of 3β-hydroxy-Δ5-C27-steroid oxidoreductase deficiency.
- Author
-
Gioiello, Antimo, Cerra, Bruno, Zhang, Wujuan, Vallerini, Gian Paolo, Costantino, Gabriele, Franco, Francesca De, Passeri, Daniela, Pellicciari, Roberto, and Setchell, Kenneth D.R.
- Subjects
- *
BILE acids , *CHEMICAL synthesis , *GENETIC disorders , *OXIDOREDUCTASES , *CHENODEOXYCHOLIC acid , *BIOMARKERS , *REVERSE transcriptase polymerase chain reaction - Abstract
Deficiency of 3β-hydroxy-Δ 5 -C 27 -steroid oxidoreductase (HSD3B7), an enzyme catalyzing the second step in the pathway for bile acid synthesis, leads to a complete lack of the primary bile acids, cholic and chenodeoxycholic acids, and the accumulation of 3β,7α-dihydroxy- and 3β,7α,12α-trihydroxy-Δ 5 -cholenoic acids. Patients affected by this autosomal recessive genetic defect develop cholestatic liver disease that is clinically responsive to primary bile acid therapy. Reference standards of these compounds are needed to facilitate diagnosis and to accurately quantify biochemical responses to therapy. Described are a novel synthesis of atypical bile acids that characterize the HSD3B7 deficiency and their effect on bile acid-activated nuclear receptors, target genes and cytochromes involved in bile acid homeostasis and detoxification. The failure of 3β-hydroxy-Δ 5 -cholenoic acids to function as FXR, PXR and CAR agonists and to exert hepatoprotective actions explains the mechanism for progressive cholestatic liver disease in patients with HSD3B7 deficiency. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
17. BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition.
- Author
-
Gabellini, Chiara, De Luca, Teresa, Trisciuoglio, Daniela, Desideri, Marianna, Di Martile, Marta, Passeri, Daniela, Candiloro, Antonio, Biffoni, Mauro, Rizzo, Maria Giulia, Orlandi, Augusto, and Del Bufalo, Donatella
- Subjects
- *
NEOVASCULARIZATION , *BCL-2 proteins , *HYPOXEMIA , *APOPTOSIS , *VASCULAR endothelial growth factors , *HYPOXIA-inducible factor 1 , *ENDOTHELIAL cells , *CANCER cell proliferation - Abstract
Beyond its classical role as apoptosis inhibitor, bcl-2 protein promotes tumor angiogenesis and the removal of N-terminal bcl-2 homology (BH4) domain abrogates bcl-2-induced hypoxia-inducible factor 1 (HIF-1)-mediated vascular endothelial growth factor (VEGF) expression in hypoxic cancer cells. Using M14 human melanoma cell line and its derivative clones stably overexpressing bcl-2 wild-type or deleted of its BH4 domain, we found that conditioned media (CM) from cells expressing BH4-deleted bcl-2 protein showed a reduced capability to increase in vitro human endothelial cells proliferation and differentiation, and in vivo neovascularization compared with CM from cells overexpressing wild-type bcl-2. Moreover, xenografts derived from cells expressing bcl-2 lacking BH4 domain showed a reduction of metastatic potential compared with tumors derived from wild-type bcl-2 transfectants injection. Stably expressing the Flag-tagged N-terminal sequence of bcl-2 protein, encompassing BH4 domain, we found that this domain is sufficient to enhance the proangiogenic HIF-1/VEGF axis under hypoxic condition. Indeed, lacking of BH4 domain abolishes the interaction between bcl-2 and HIF-1α proteins and the capability of exogenous bcl-2 protein to localize in the nucleus. Moreover, when endoplasmic reticulum-targeted bcl-2 protein is overexpressed in cells, this protein lost the capability to synergize with hypoxia to induce the proangiogenic HIF-1/VEGF axis as shown by wild-type bcl-2 protein. These results demonstrate that BH4 domain of bcl-2 is required for the ability of this protein to increase tumor angiogenesis and progression and indicate that bcl-2 nuclear localization may be required for bcl-2-mediated induction of HIF-1/VEGF axis. [ABSTRACT FROM PUBLISHER]
- Published
- 2013
- Full Text
- View/download PDF
18. Asymmetric synthesis of the four diastereoisomers of a novel non-steroidal farnesoid X receptor (FXR) agonist: Role of the chirality on the biological activity.
- Author
-
Marinozzi, Maura, Carotti, Andrea, Sardella, Roccaldo, Buonerba, Federica, Ianni, Federica, Natalini, Benedetto, Passeri, Daniela, Rizzo, Giovanni, and Pellicciari, Roberto
- Subjects
- *
DIASTEREOISOMERS , *ASYMMETRIC synthesis , *FARNESOID X receptor , *CHIRALITY , *BIOACTIVE compounds , *ISOMERS - Abstract
Abstract: An asymmetric synthetic strategy was designed for the preparation of the four possible diastereoisomers of 3,6-dimethyl-1-(2-methylphenyl)-4-(4-phenoxyphenyl)-4,8-dihydro-1H-pyrazolo[3,4-e][1,4]thiazepin-7-one, a non-steroidal FXR agonist, we recently discovered following a virtual screening approach. The results obtained from an AlphaScreen assay clearly demonstrated that only the isomer endowed with 4R,6S absolute configuration is responsible for the biological activity. A deep investigation of the different putative binding modes adopted by these enantiomerically pure ligands using computational modeling studies confirmed the enantioselectivity of FXR towards this class of molecules. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
19. The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effects
- Author
-
Cassinelli, Giuliana, Zuco, Valentina, Petrangolini, Giovanna, De Cesare, Michelandrea, Tortoreto, Monica, Lanzi, Cinzia, Cominetti, Denis, Zaffaroni, Nadia, Orlandi, Augusto, Passeri, Daniela, Meco, Daniela, Di Francesco, Angela Maria, Riccardi, Riccardo, Bucci, Federica, Pisano, Claudio, and Zunino, Franco
- Subjects
- *
PEDIATRICS , *SARCOMA , *CAMPTOTHECIN , *ANTINEOPLASTIC agents , *TREATMENT effectiveness , *RHABDOMYOSARCOMA - Abstract
Abstract: Namitecan (ST1968), a novel hydrophilic camptothecin analog of the 7-oxyiminomethyl series, was selected for clinical development on the basis of its promising preclinical efficacy. Since there is clinical evidence of efficacy of camptothecins against pediatric tumors, this study was performed to explore the antitumor and antiangiogenic activity of the camptothecin derivative in pediatric sarcoma models. With the exception of an undifferentiated rhabdomyosarcoma (A204), namitecan exhibited curative efficacy even at well-tolerated suboptimal doses in a panel of five models. The good therapeutic index of namitecan likely reflected a high and persistent drug accumulation at tumor site. The four responsive tumors were characterized by high topoisomerase I expression. In the RD/TE-671 rhabdomyosarcoma model the drug activity was associated with a marked antiangiogenic effect, which was consistent with the downregulation of proangiogenic factors, including VEGF, bFGF and the multifunctional chemokines CCL-2 and CXCL16. In agreement with this modulation, the combination of low doses of namitecan with other antiangiogenic agents, such as bevacizumab (a humanized anti-VEGF antibody) and sunitinib (a multitarget tyrosine kinase inhibitor effective against receptors implicated in the angiogenesis process), enhanced the antitumor effects. In conclusion, this preclinical study provides evidence of curative efficacy of namitecan at well-tolerated doses against pediatric sarcoma models, likely reflecting a contribution of antiangiogenic effects. Based on the promising therapeutic profile, namitecan is a good candidate for clinical evaluation in pediatric sarcomas. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
20. Pyrazole[3,4-e][1,4]thiazepin-7-one derivatives as a novel class of Farnesoid X Receptor (FXR) agonists
- Author
-
Marinozzi, Maura, Carotti, Andrea, Sansone, Emanuele, Macchiarulo, Antonio, Rosatelli, Emiliano, Sardella, Roccaldo, Natalini, Benedetto, Rizzo, Giovanni, Adorini, Luciano, Passeri, Daniela, De Franco, Francesca, Pruzanski, Mark, and Pellicciari, Roberto
- Subjects
- *
PYRAZOLES , *FARNESOID X receptor , *LUCIFERASES , *AZOLES , *ANTIPYRINE , *BENZOSELENADIAZOLE - Abstract
Abstract: A virtual screening procedure was applied to the discovery of structurally diverse non-steroidal Farnesoid X Receptor (FXR) agonists. From 117 compounds selected by virtual screening, a total of 47 compounds were found to be FXR agonists, with 34 of them showing activity below a concentration of 20μM. 1H-Pyrazole[3,4-e][1,4]thiazepin-7-one-based hit compound 7 was chosen for hit-to-lead optimization. A large number of 1H-pyrazole[3,4-e][1,4]thiazepin-7-one derivatives was designed, synthesized, and evaluated by a cell-based luciferase transactivation assay for their agonistic activity against FXR. Most of them exhibited low micromolar range of potency and very high efficacy. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
21. The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms.
- Author
-
Ciuffreda, Ludovica, Sanza, Cristina, Cesta Incani, Ursula, Eramo, Adriana, Desideri, Marianna, Biagioni, Francesca, Passeri, Daniela, Falcone, Italia, Sette, Giovanni, Bergamo, Paola, Anichini, Andrea, Sabapathy, Kanaga, McCubrey, James, Ricciardi, Maria, Tafuri, Agostino, Blandino, Giovanni, Orlandi, Augusto, Maria, Ruggero, Cognetti, Francesco, and Bufalo, Donatella
- Subjects
- *
MITOGENS , *PROTEIN kinases , *PHOSPHATASES , *RAPAMYCIN , *TUMORS - Abstract
The mitogen-activated protein kinase (MAPK) and PI3K pathways are regulated by extensive crosstalk, occurring at different levels. In tumors, transactivation of the alternate pathway is a frequent 'escape' mechanism, suggesting that combined inhibition of both pathways may achieve synergistic antitumor activity. Here we show that, in the M14 melanoma model, simultaneous inhibition of both MEK and mammalian target of rapamycin (mTOR) achieves synergistic effects at suboptimal concentrations, but becomes frankly antagonistic in the presence of relatively high concentrations of MEK inhibitors. This observation led to the identification of a novel crosstalk mechanism, by which either pharmacologic or genetic inhibition of constitutive MEK signaling restores phosphatase and tensin homolog (PTEN) expression, both in vitro and in vivo, and inhibits downstream signaling through AKT and mTOR, thus bypassing the need for double pathway blockade. This appears to be a general regulatory mechanism and is mediated by multiple mechanisms, such as MAPK-dependent c-Jun and miR-25 regulation. Finally, PTEN upregulation appears to be a major effector of MEK inhibitors' antitumor activity, as cancer cells in which PTEN is inactivated are consistently more resistant to the growth inhibitory and anti-angiogenic effects of MEK blockade. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
22. NAADP-Dependent Ca2+ Signaling Controls Melanoma Progression, Metastatic Dissemination and Neoangiogenesis.
- Author
-
Favia, Annarita, Pafumi, Irene, Desideri, Marianna, Padula, Fabrizio, Montesano, Camilla, Passeri, Daniela, Nicoletti, Carmine, Orlandi, Augusto, Del Bufalo, Donatella, Sergi, Manuel, Ziparo, Elio, Palombi, Fioretta, and Filippini, Antonio
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.